You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 30, 2025

Details for Patent: 6,146,662


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,146,662
Title: System for delaying drug delivery up to seven hours
Abstract:A dosage form is disclosed comprising means for delaying the delivery of drug from the dosage form following the administration of the dosage form to a patient in need of drug therapy.
Inventor(s): Jao; Frank (San Jose, CA), Wong; Patrick S.-L. (Palo Alto, CA), Huynh; Hoa T. (Fremont, CA), Mc Chesney; Kathy (Cupertino, CA), Wat; Pamela K. (Santa Clara, CA)
Assignee: ALZA Corporation (Mountain View, CA)
Application Number:08/036,648
Patent Claim Types:
see list of patent claims
Dosage form; Delivery; Composition; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of US Patent 6,146,662

Introduction

When navigating the complex world of patents, understanding the scope and claims of a particular patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of US Patent 6,146,662, providing a comprehensive analysis of its scope, claims, and the broader patent landscape.

What is a Patent?

Before diving into the specifics of US Patent 6,146,662, it is essential to understand what a patent is. A patent is a form of intellectual property that gives the patent holder the exclusive right to make, use, and sell an invention for a specified period, typically 20 years from the filing date of the patent application[4].

US Patent 6,146,662 Overview

To analyze US Patent 6,146,662, we need to look at its key components:

Title and Abstract

The title and abstract provide a brief overview of the invention. While the specific details of US Patent 6,146,662 are not provided in the sources, generally, the title would indicate the main subject of the invention, and the abstract would summarize its key features and purposes.

Claims

The claims section is the most critical part of a patent as it defines the scope of the invention. Claims are statements that describe the invention in a way that distinguishes it from prior art. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[4].

Analyzing the Claims

To analyze the claims of US Patent 6,146,662, one would typically follow these steps:

Identify Independent Claims

Independent claims are the broadest claims and define the core of the invention. These claims should be carefully examined to understand the fundamental aspects of the invention.

Examine Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations. These claims help to further define the invention and can provide more specific details about its implementation.

Claim Construction

Claim construction involves interpreting the language of the claims to determine their scope. This process is crucial in patent litigation and can significantly impact the enforceability of the patent.

Scope of the Invention

The scope of the invention is determined by the claims. Here are some key points to consider:

Broad vs. Narrow Claims

Broad claims cover a wider range of implementations, while narrow claims are more specific. The balance between broad and narrow claims is critical in defining the invention's scope without being too vague or too restrictive.

Prior Art Considerations

The scope of the invention must be distinguished from prior art. This involves ensuring that the claims do not cover existing technologies or inventions.

Patent Landscape

Understanding the patent landscape involves looking at related patents and the overall technological field in which the patent resides.

Technology Field

US Patent 6,146,662 would fall into one of the broad technology fields defined by the USPTO, such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, or Other[1].

Related Patents

Using tools like the USPTO's Patent Public Search or Global Dossier, one can identify related patents and understand how US Patent 6,146,662 fits into the broader patent landscape. This includes looking at patent families, citations, and office actions[4].

Statistical Context

To put the analysis into a broader statistical context:

Patent Allowance Rates

Only about 55.8% of patent applications filed at the USPTO are eventually granted without using continuation procedures. This rate has decreased over time, particularly in fields like Drugs and Medical Instruments and Computers and Communications[1].

Continuation Procedures

About 31% of progenitor applications utilize continuation procedures, which can affect the overall allowance rate and the complexity of the patent prosecution process[1].

Tools and Resources for Analysis

Several tools and resources are available for analyzing patents:

USPTO Patent Public Search

This tool provides enhanced access to prior art and allows users to search for patents, published patent applications, and other related documentation[4].

Global Dossier

This service provides access to the file histories of related applications from participating IP Offices, helping users to see the patent family and related applications[4].

Patent Assignment Search

This tool allows users to search for patent assignments and changes in ownership, which can be crucial in understanding the current status and ownership of a patent[4].

Expert Insights and Legal Considerations

Experts in the field often provide valuable insights into the patent landscape and legal considerations.

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could impact how patent disputes are handled, especially for smaller entities[2].

Patent Continuations

The use of continuation procedures is a significant aspect of patent prosecution. Experts like Alan Marco, former Chief Economist for the USPTO, have studied the impact of these procedures on the patent system[1][2].

Key Takeaways

  • Claims Analysis: The claims section is the heart of a patent, defining its scope and distinguishing it from prior art.
  • Scope of Invention: Understanding the balance between broad and narrow claims is crucial for defining the invention's scope.
  • Patent Landscape: Analyzing related patents and the broader technological field helps in understanding the patent's position.
  • Statistical Context: Knowing the overall patent allowance rates and the use of continuation procedures provides a broader understanding of the patent system.
  • Tools and Resources: Utilizing USPTO tools like Patent Public Search and Global Dossier is essential for thorough analysis.

FAQs

Q: What is the primary purpose of the claims section in a patent? A: The primary purpose of the claims section is to define the scope of the invention and distinguish it from prior art.

Q: How do continuation procedures affect the patent prosecution process? A: Continuation procedures can extend the prosecution process, allowing applicants to file additional applications related to the original (progenitor) application, which can impact the overall allowance rate and complexity of the process.

Q: What is the significance of the Global Dossier service? A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, helping users to see the patent family and related applications.

Q: Why is understanding the patent landscape important? A: Understanding the patent landscape helps in identifying related patents, citations, and office actions, which is crucial for determining the novelty and non-obviousness of an invention.

Q: What resources are available for searching and analyzing patents? A: Resources include the USPTO's Patent Public Search, Global Dossier, Patent and Trademark Resource Centers (PTRCs), and the Public Search Facility.

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. Administrative Conference of the United States. (2022). U.S. Patent Small Claims Court.
  3. United States Patent and Trademark Office. (2022). Patent and patent application Claims data.
  4. United States Patent and Trademark Office. (2022). Search for patents.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,146,662

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 6,146,662

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2255092 ⤷  Try for Free
Australia 654871 ⤷  Try for Free
Austria 165000 ⤷  Try for Free
Canada 2105165 ⤷  Try for Free
European Patent Office 0591389 ⤷  Try for Free
Germany 69225135 ⤷  Try for Free
Spain 2114562 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.